Comments: IL HB1721 | 2021-2022 | 102nd General Assembly

Bill Title: Amends the Illinois Food, Drug and Cosmetic Act. Requires a manufacturer of a prescription drug that is sold, offered for sale, or distributed in this State, or placed on a formulary to be eligible for payment, co-payment, or reimbursement in this State, to notify the Department of Public Health of specified information concerning active pharmaceutical ingredients.

Sponsorship: Bipartisan Bill

Status: (Introduced - Dead) 2021-04-23 - Rule 19(a) / Re-referred to Rules Committee [HB1721 Detail]

Text: Latest bill text (Introduced) [HTML]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2021 Illinois HB1721 at this time.

feedback